A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
Do Postmarketing Surveillance Studies Represent Real-World Populations?: A Comparison of Patient Characteristics and Outcomes After Carotid Artery Stenting
2011
Circulation
Background-To evaluate outcomes after carotid artery stenting in larger real-world populations, the Food and Drug Administration mandated that companies conduct postmarketing surveillance (PMS) studies of approved stent systems. Whether PMS studies are representative of carotid artery stenting in routine clinical practice has not been established. Methods and Results-Within the National Cardiovascular Database Registry-Carotid Artery Revascularization and Endarterectomy (NCDR CARE) Registry, we
doi:10.1161/circulationaha.110.991075
pmid:21422383
fatcat:qz4hspn3uva6znekxjarmkcdnu